2024. Efficacy and Safety of Ruxolitinib Cream for the Treatment of Moderate to Severe Chronic Hand Eczema: Top-Line Results From a 16-Week, Multicenter, Randomized, Double-Blind Study. SKIN The Journal of Cutaneous Medicine. 8, 6 (Nov. 2024), s500. DOI:https://doi.org/10.25251/skin.8.supp.500.